Treleaven J G, Mehta J
Leukaemia Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
J Hematother. 1992 Fall;1(3):215-23. doi: 10.1089/scd.1.1992.1.215.
A number of malignant diseases are responsive to supralethal myelotoxic high-dose chemoradiotherapy, and can be treated with hematopoietic stem cell rescue. The number of genetic diseases correctable by replacement of defective pluripotent stem cells with normal stem cells or through gene transfer is ever-increasing. In all these cases, pluripotent hematopoietic stem cells need to be infused, which can be obtained directly from the bone marrow or from the peripheral blood with or without the aid of mobilizing strategies. This article is a detailed review of the technical and medical aspects of stem cell collection from the bone marrow and the peripheral blood.
许多恶性疾病对超致死性骨髓毒性大剂量放化疗有反应,并且可以通过造血干细胞救援进行治疗。通过用正常干细胞替代有缺陷的多能干细胞或通过基因转移可纠正的遗传疾病的数量正在不断增加。在所有这些情况下,都需要输注多能造血干细胞,这些干细胞可以直接从骨髓中获得,也可以在有或没有动员策略的帮助下从外周血中获得。本文详细综述了从骨髓和外周血中采集干细胞的技术和医学方面的内容。